Patents by Inventor Don Edgar Griswold

Don Edgar Griswold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
    Patent number: 7053099
    Abstract: Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: May 30, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Ralph Hall, Don Edgar Griswold, David C. Underwood
  • 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors
    Patent number: 7053098
    Abstract: Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: May 30, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Jeffrey C. Boehm, Don Edgar Griswold, David C. Underwood
  • 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
    Patent number: 6982270
    Abstract: Substituted quinazolinone compounds of formula (I) and compositions thereof for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: January 3, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Jeffrey C. Boehm, Don Edgar Griswold, David C. Underwood
  • Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
    Publication number: 20040234499
    Abstract: The present invention relates to therapeutic methods involving the use of at least one asthma related anti-IL-13 human Ig derived protein, as well as such proteins and isolated nucleic acids that encode at least one asthma related Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including pharmceutical compositions, methods and devices.
    Type: Application
    Filed: February 27, 2004
    Publication date: November 25, 2004
    Inventors: David Shealy, Don Edgar Griswold, George A. Heavner, Li Li
  • 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
    Patent number: 6759410
    Abstract: The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines of formula (1), or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: July 6, 2004
    Assignee: SmithLine Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Ralph Hall, Don Edgar Griswold, David C. Underwood
  • Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
    Publication number: 20040018195
    Abstract: The present invention relates to at least one novel diabetes related human Ig derived protein or specified portion or variant, including isolated nucleic acids that encode at least one diabetes related Ig derived protein or specified portion or variant, diabetes related Ig derived protein or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: March 26, 2003
    Publication date: January 29, 2004
    Inventors: Don Edgar Griswold, Jian Li, Li Li
  • Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
    Publication number: 20030235555
    Abstract: The present invention relates to therapeutic methods involving the use of at least one asthma related anti-IL-13 human Ig derived protein, as well as such proteins and isolated nucleic acids that encode at least one asthma related Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including pharmceutical compositions, methods and devices.
    Type: Application
    Filed: April 7, 2003
    Publication date: December 25, 2003
    Inventors: David Shealey, Don Edgar Griswold, Li Li
  • Methods of treating psoriasis employing substituted azaspiranes
    Patent number: 5981538
    Abstract: Invented is a method of treatment of psoriasis in a mammal in need thereof which comprises administering to such mammal an effective amount of a substituted azaspirane.
    Type: Grant
    Filed: January 29, 1997
    Date of Patent: November 9, 1999
    Assignee: AnorMED Inc.
    Inventors: Alison Mary Badger, Don Edgar Griswold
  • Method for treating atopic dermatitis and contact dermatitis
    Patent number: 5929096
    Abstract: This invention relates to a method of treating atopic and contact dermatitis using compounds of formula (I) ##STR1## wherein the terms A, Z, R, R.sub.1, R.sub.2, R.sub.3 and M are herein defined.
    Type: Grant
    Filed: August 28, 1997
    Date of Patent: July 27, 1999
    Assignee: SmithKline Beecham Corporation
    Inventor: Don Edgar Griswold
  • Medicaments
    Patent number: 5824696
    Abstract: The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of chronic inflammatory disease states.
    Type: Grant
    Filed: September 1, 1993
    Date of Patent: October 20, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Don Edgar Griswold, John Wharton